46512 Federal Register / Vol. 82, No. 192 / Thursday, October 5, 2017 / Notices 

listening session is to exchange 

information about the public health 

importance of hypoglycemia, and 

discuss federal efforts to reduce 

preventable hypoglycemia from diabetes 

medications. The Department of Health 

and Human Services invites public and 

private professionals, organizations, and 

consumer representatives to register to 

attend this listening session at https://

health.gov/news/. 

DATES: The public listening session will 

be held on November 1, 2017, from 9:00 

a.m. to 4:00 p.m. EDT. 

ADDRESSES: The meeting will only be 

accessible by attendance in-person. For 

in-person participants, the meeting will 

take place in the Hubert H. Humphrey 

Building, Room 800, 200 Independence 

Ave. SW., Washington, DC 20201. 

FOR FURTHER INFORMATION CONTACT: 

Ndome Essoka, Health Policy Fellow, 

Office of Disease Prevention and Health 

Promotion, Office of the Assistant 

Secretary for Health, U.S. Department of 

Health and Human Services, 1101 

Wootton Parkway, Suite LL100, 

Rockville, MD 20852, phone: 240–453– 

8217, email: ndome.essoka@hhs.gov or 

OHQ@hhs.gov (please indicate in the 

subject line: Partnering to Prevent 

Hypoglycemia). 

SUPPLEMENTARY INFORMATION: In 

September 2012, in response to 

heightened awareness of the 

contribution of adverse drug events 

(ADEs) to the burden of health carerelated harm and costs, the Office of the 

Assistant Secretary for Health (OASH) 

marshaled the wide-ranging and diverse 

resources of federal partners to form an 

extensive interagency partnership, the 

Federal Interagency Steering Committee 

and Workgroups for Adverse Drug 

Events, whose goals would be to 

develop the ADE Action Plan, as well as 

identify measures to track national 

progress in reducing ADEs and targets to 

meet based on those measures. 

ODPHP, in conjunction with the 

Federal Interagency Steering Committee 

and three Federal Interagency 

Workgroups, developed and released 

the final ADE Action Plan in 2014. The 

ADE Action Plan seeks to engage all 

stakeholders in coordinated efforts to 

reduce ADEs that are not only clinically 

significant but largely preventable. 

Inpatient and outpatient use of 

anticoagulants, diabetes agents, and 

opioid analgesics (with specific focus on 

ADEs from therapeutic use of opioids) 

contribute to the reason why ADEs 

account for the greatest number of 

measurable harms. The ADE Action 

Plan identifies the federal government’s 

highest priority strategies and 

opportunities for advancement, which 

will have the greatest impact on 

reducing ADEs. Implementation of these 

strategies is expected to result in safer 

and higher quality health care services, 

reduced health care costs, informed and 

engaged consumers and, ultimately, 

improved health outcomes. For more 

information on the ADE Action Plan, 

visit https://health.gov/hcq/ade-actionplan.asp. 

Purpose of the Meeting: ODPHP is 

hosting a listening session titled, 

‘‘Reducing Preventable Hypoglycemia.’’ 

The purpose of this listening session is 

to exchange information about the 

public health importance of 

hypoglycemia, and discuss federal 

efforts to reduce preventable 

hypoglycemia from diabetes 

medications. This information may 

assist ODPHP and federal partners in 

identifying how patients and providers 

are affected by hypoglycemia, where 

gaps in knowledge exist, and how 

information can be better disseminated. 

Meeting Registration: There is no 

registration fee to attend the public 

listening session. Early registration is 

recommended because seating is 

limited, and registration will be on a 

first-come, first-served basis. There will 

be no onsite registration. Persons 

interested in attending this listening 

session must register online at https://

health.gov/news/. For those without 

Internet access, please contact Ndome 

Essoka (see FOR FURTHER INFORMATION

CONTACT) to register. If you need special 

accommodations due to a disability, 

please contact Ndome Essoka at least 

seven days in advance. 

Dated: September 29, 2017. 

Don Wright, 

Deputy Assistant Secretary for Health 

(Disease Prevention and Health Promotion). 

[FR Doc. 2017–21503 Filed 10–4–17; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Advisory Council on Alzheimer’s 

Research, Care, and Services; Meeting 

AGENCY: Assistant Secretary for 

Planning and Evaluation, HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces the 

public meeting of the Advisory Council 

on Alzheimer’s Research, Care, and 

Services (Advisory Council). The 

Advisory Council on Alzheimer’s 

Research, Care, and Services provides 

advice on how to prevent or reduce the 

burden of Alzheimer’s disease and 

related dementias on people with the 

disease and their caregivers. During the 

October meeting, the Advisory Council 

will welcome its new members and 

invite them to share their experiences 

and where they see the Council going 

over the length of their terms. The 

Advisory Council will also spend some 

time discussing the process of 

developing recommendations and how 

those recommendations relate to the 

National Plan. The Council will then 

spend much of the meeting discussing 

the National Research Summit on Care, 

Services, and Supports for Persons with 

Dementia and Their Caregivers, held on 

October 16–17. 

DATES: The meeting will be held on 

October 27, 2017 from 9:00 a.m. to 5:00 

p.m. EDT. 

ADDRESSES: The meeting will be held in 

Room 800 in the Hubert H. Humphrey 

Building, 200 Independence Avenue 

SW., Washington, DC 20201. 

Comments: Time is allocated in the 

afternoon on the agenda to hear public 

comments. The time for oral comments 

will be limited to two (2) minutes per 

individual. In lieu of oral comments, 

formal written comments may be 

submitted for the record to Rohini 

Khillan, OASPE, 200 Independence 

Avenue SW., Room 424E, Washington, 

DC 20201. Comments may also be sent 

to napa@hhs.gov. Those submitting 

written comments should identify 

themselves and any relevant 

organizational affiliations. 

FOR FURTHER INFORMATION CONTACT: 

Rohini Khillan (202) 690–5932, 

rohini.khillan@hhs.gov. Note: Seating 

may be limited. Those wishing to attend 

the meeting must send an email to 

napa@hhs.gov and put ‘‘October 27 

Meeting Attendance’’ in the Subject line 

by Tuesday, October 17, so that their 

names may be put on a list of expected 

attendees and forwarded to the security 

officers at the Department of Health and 

Human Services. Any interested 

member of the public who is a non-U.S. 

citizen should include this information 

at the time of registration to ensure that 

the appropriate security procedure to 

gain entry to the building is carried out. 

Although the meeting is open to the 

public, procedures governing security 

and the entrance to Federal buildings 

may change without notice. If you wish 

to make a public comment, you must 

note that within your email. 

SUPPLEMENTARY INFORMATION: Notice of 

these meetings is given under the 

Federal Advisory Committee Act (5 

U.S.C. App. 2, section 10(a)(1) and 

(a)(2)). 

Topics of the Meeting: During the 

October meeting, the Advisory Council 

will welcome its new members and 

invite them to share their experiences 


ethrower on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 82, No. 192 / Thursday, October 5, 2017 / Notices 46513 

and where they see the Council going 

over the length of their terms. The 

Advisory Council will also spend some 

time discussing the process of 

developing recommendations and how 

those recommendations relate to the 

National Plan. The Council will then 

spend much of the meeting discussing 

the National Research Summit on Care, 

Services, and Supports for Persons with 

Dementia and Their Caregivers, held on 

October 16–17. 

Procedure and Agenda: This meeting 

is open to the public. Please allow 30 

minutes to go through security and walk 

to the meeting room. The meeting will 

also be webcast at www.hhs.gov/live. 

Authority: 42 U.S.C. 11225; Section 

2(e)(3) of the National Alzheimer’s 

Project Act. The panel is governed by 

provisions of Public Law 92–463, as 

amended (5 U.S.C. Appendix 2), which 

sets forth standards for the formation 

and use of advisory committees. 

Dated: September 22, 2017. 

John R. Graham, 

Acting Assistant Secretary for Planning and 

Evaluation. 

[FR Doc. 2017–21399 Filed 10–4–17; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Solicitation of Nominations for 

Appointment to the Advisory 

Committee on Minority Health 

AGENCY: Office of Minority Health, 

Office of the Secretary, Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS), Office of 

Minority Health (OMH), is seeking 

nominations of qualified candidates to 

be considered for appointment as a 

member of the Advisory Committee on 

Minority Health (hereafter referred to as 

the ‘‘Committee or ACMH’’). In 

accordance with Public Law 105–392, 

the Committee provides advice to the 

Deputy Assistant Secretary for Minority 

Health on improving the health of racial 

and ethnic minority groups, and on the 

development of goals and specific 

program activities of OMH designed to 

improve the health status and outcomes 

of racial and ethnic minorities. 

Nominations of qualified candidates are 

being sought to fill vacancies on the 

Committee. 

DATES: Nominations for membership on 

the Committee must be received no later 

than 5:00 p.m. EST on January 3, 2018, 

at the address listed below. 

ADDRESSES: All nominations should be 

mailed to Dr. Minh Wendt, Designated 

Federal Officer, Advisory Committee on 

Minority Health, Office of Minority 

Health, Department of Health and 

Human Services, 1101 Wootton 

Parkway, Suite 600, Rockville, MD 

20852. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Minh Wendt, Designated Federal 

Officer, Advisory Committee on 

Minority Health, Office of Minority 

Health, Department of Health and 

Human Services, Tower Building, 1101 

Wootton Parkway, Suite 600, Rockville, 

Maryland 20852. Phone: 240–453–8222; 

fax: 240–453–8223. 

A copy of the ACMH charter and list 

of the current membership can be 

obtained by contacting Dr. Wendt or by 

accessing the Web site managed by 

OMH at www.minorityhealth.hhs.gov. 

Information about ACMH activities can 

be found on the OMH Web site under 

the heading About OMH. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Public Law 105–392, the Secretary of 

Health and Human Services established 

the ACMH. The Committee provides 

advice to the Deputy Assistant Secretary 

for Minority Health in carrying out the 

duties stipulated under Public Law 105– 

392. This includes providing advice on 

improving the health of racial and 

ethnic minority populations and in the 

development of goals and specific 

program activities of OMH, which are 

to: 

(1) Establish short-range and longrange goals and objectives and 

coordinate all other activities within the 

Public Health Service that relate to 

disease prevention, health promotion, 

service delivery, and research impacting 

racial and ethnic minority populations; 

(2) Enter into interagency agreements 

with other agencies of the Public Health 

Service; 

(3) Support research, demonstrations, 

and evaluations to test new and 

innovative models; 

(4) Increase knowledge and 

understanding of health risk factors; 

(5) Develop mechanisms that support 

better information dissemination, 

education, prevention, and service 

delivery to individuals from 

disadvantaged backgrounds, including 

individuals who are members of racial 

or ethnic minority groups; 

(6) Ensure that the National Center for 

Health Statistics collects data on the 

health status of each minority group; 

(7) Enter into contracts with public 

and non-profit private providers of 

primary health services for the purpose 

of increasing the access of individuals 

who lack proficiency in speaking the 

English language by developing and 

carrying out programs to provide 

bilingual or interpretive services; 

(8) Support a national minority health 

resource center which provides 

resources to the public such as 

information services and assistance in 

capacity building; 

(9) Carry out programs to improve 

access to health care services for 

individuals with limited proficiency in 

speaking the English language; and 

(10) Advise in matters related to the 

development, implementation, and 

evaluation of health professions 

education in decreasing disparities in 

health care outcomes, including cultural 

competency as a method of eliminating 

health disparities. 

Management and support services for 

the ACMH are provided by OMH. 

Nominations: The Committee is 

composed of 12 voting members. The 

Committee composition also can 

include non-voting ex officio members. 

This announcement is seeking 

nominations for voting members. Voting 

members of the Committee are 

appointed by the Secretary from 

individuals who are not officers or 

employees of the federal government 

and who have expertise regarding issues 

of minority health. To qualify for 

consideration of appointment to the 

Committee, an individual must possess 

demonstrated experience and expertise 

working on issues impacting the health 

of racial and ethnic minority 

populations. The Committee charter 

stipulates that the racial and ethnic 

minority groups shall be equally 

represented on the Committee 

membership. ACMH is comprised of 

members who represent the health 

interest of Hispanics/Latinos; Blacks/ 

African Americans; American Indians 

and Alaska Natives; and/or Asian 

Americans, Native Hawaiians, and other 

Pacific Islanders. 

There are a total of four impending 

vacancies on the Committee: Three 

vacancies on the ACMH that impact the 

representation for the health interests of 

Hispanics/Latinos and one vacancy that 

impacts the representation of Asian 

Americans, Native Hawaiians, and other 

Pacific Islanders. OMH is particularly 

seeking nominations for individuals 

who can represent the health interests of 

these racial and ethnic minority groups. 

Nominations that are received for 

individuals to represent other racial and 

ethnic minority groups also will be 

accepted. These applications will be 

retained in files that are maintained by 

OMH on potential candidates to be 

considered for the ACMH. 

Professional/Technical Expertise: 

Nominees must have expertise in issues 


ethrower on DSK3G9T082PROD with NOTICES